Tech Company Financing Transactions

Kinaset Therapeutics Funding Round

Kinaset Therapeutics, based in Medfield, scored $103 million in investment from Forge Life Science Partners, RA Capital Management and 5AM Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

10 Knollwood Rd.
Medfield, MA 02052
USA

Phone

(508) 858-5810

Website

www.kinasettherapeutics.com

Email Address

[email protected]

Overview

Kinaset Therapeutics intends to develop novel therapeutics that can positively impact people affected by intractable diseases, including severe asthma. The firm's novel lead asset and experienced team combine a potentially best in class approach to treating severe asthma with a group of dedicated drug development experts working to bring the therapy forward.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Robert Clarke

        

VP - Bus. Development

Roger Heerman

        

VP - Bus. Development

Frazer Morgan

        

Browse more venture capital transactions:

Prev: 1/12/2026: Hadrian venture capital transaction
Next: 1/12/2026: Torq venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are derived from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary